What you need to know about new RSV immunizations for children and adults

During this webinar, CDC experts will provide an overview of the burden of RSV on pediatric and older adult populations, and share information about the new ACIP recommendations for protecting adults 60 years of age and older against RSV. They will also discuss the new ACIP recommendations about the new long-acting monoclonal antibody to protect infants from RSV. An expert from AAP will advise providers on proper billing and coding for administering the long-acting monoclonal antibody.